美国癌症患者和癌症幸存者中补充和替代医学使用的流行率和未披露情况。
Prevalence and Nondisclosure of Complementary and Alternative Medicine Use in Patients With Cancer and Cancer Survivors in the United States.
机构信息
Department of Radiation Oncology, University of Texas Southwestern, Dallas.
Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas.
出版信息
JAMA Oncol. 2019 May 1;5(5):735-737. doi: 10.1001/jamaoncol.2019.0349.
Abstract
This cross-sectional study analyzes the proportion of patients with cancer and cancer survivors who use complementary and alternative medicine (CAM) without disclosing this information to their physicians.
摘要
本横断面研究分析了在向医生隐瞒信息的情况下，癌症患者和癌症幸存者使用补充和替代医学（CAM）的比例。
相似文献
1
Prevalence and Nondisclosure of Complementary and Alternative Medicine Use in Patients With Cancer and Cancer Survivors in the United States.美国癌症患者和癌症幸存者中补充和替代医学使用的流行率和未披露情况。
JAMA Oncol. 2019 May 1;5(5):735-737. doi: 10.1001/jamaoncol.2019.0349.
2
Cancer survivors' disclosure of complementary health approaches to physicians: the role of patient-centered communication.癌症幸存者向医生透露补充性健康方法：以患者为中心的沟通的作用。
Cancer. 2015 Mar 15;121(6):900-7. doi: 10.1002/cncr.29138. Epub 2014 Nov 11.
3
Cancer and Complementary Therapies: Current Trends in Survivors' Interest and Use.癌症与辅助疗法：幸存者兴趣与使用的当前趋势
Integr Cancer Ther. 2018 Sep;17(3):844-853. doi: 10.1177/1534735418762496. Epub 2018 Apr 9.
4
Use of non-conventional medicine and lifestyle change among cancer survivors: evidence from the national VICAN survey.癌症幸存者中非常规医学的使用和生活方式的改变：来自国家 VICAN 调查的证据。
J Cancer Surviv. 2020 Dec;14(6):779-789. doi: 10.1007/s11764-020-00892-w. Epub 2020 May 27.
5
Complementary and Alternative Medicine Use Among Overweight and Obese Cancer Survivors in the United States.美国超重和肥胖癌症幸存者使用补充和替代医学的情况。
Integr Cancer Ther. 2015 Nov;14(6):503-14. doi: 10.1177/1534735415589347. Epub 2015 Jun 4.
6
Varieties of silence - a mixed-methods study exploring reasons and justifications for nondisclosure of the use of complementary therapies to physicians in Finland.各种沉默——一项混合方法研究，旨在探讨芬兰人向医生隐瞒使用补充疗法的原因和理由。
BMC Complement Med Ther. 2024 Sep 19;24(1):336. doi: 10.1186/s12906-024-04640-w.
7
A hard push to help protect survivors of childhood cancer.为帮助保护儿童癌症幸存者而全力推动。
Cancer Cytopathol. 2018 Nov;126(11):893-894. doi: 10.1002/cncy.22079.
8
Complementary medicine use in US adults with a history of colorectal cancer: a nationally representative survey.美国结直肠癌病史成年人中补充医学的使用：一项全国代表性调查。
Support Care Cancer. 2021 Jan;29(1):271-278. doi: 10.1007/s00520-020-05494-x. Epub 2020 May 1.
9
Patient disclosure of the use of complementary and alternative medicine to their obstetrician/gynaecologist.患者向其妇产科医生透露使用补充和替代医学的情况。
J Obstet Gynaecol. 2011;31(1):59-61. doi: 10.3109/01443615.2010.531303.
10
Nondisclosure of Complementary and Alternative Medicine Use to Primary Care Physicians: Findings From the 2012 National Health Interview Survey.向初级保健医生隐瞒补充和替代医学的使用情况：2012年美国国家健康访谈调查结果
JAMA Intern Med. 2016 Apr;176(4):545-6. doi: 10.1001/jamainternmed.2015.8593.
引用本文的文献
1
Utilization of complementary, alternative, and integrative medicine practices among US adults with and without a diagnosis of cancer.美国有和没有癌症诊断的成年人对补充医学、替代医学和整合医学疗法的使用情况。
Support Care Cancer. 2025 Jun 14;33(7):582. doi: 10.1007/s00520-025-09627-y.
2
The use of complementary and alternative medicine among cancer patients in Hawaii.夏威夷癌症患者对补充和替代医学的使用情况。
BMC Complement Med Ther. 2025 May 8;25(1):167. doi: 10.1186/s12906-025-04912-z.
3
Integrative Management of Cancer Pain: A Scoping Review of the Literature.癌症疼痛的综合管理：文献综述
Cancer Med. 2025 May;14(9):e70833. doi: 10.1002/cam4.70833.
4
Factors influencing the utilization of Traditional Chinese Medicine in cancer treatment: a qualitative meta-synthesis of patient and healthcare professional perspectives.影响中医在癌症治疗中应用的因素：基于患者和医护人员观点的定性元分析
Front Med (Lausanne). 2025 Mar 5;12:1501918. doi: 10.3389/fmed.2025.1501918. eCollection 2025.
5
Enhancing patient activation: a controlled implementation study of an interprofessional evidence-based counseling program for complementary and integrative healthcare in cancer patients ('CCC-Integrativ').增强患者的自我管理能力：一项针对癌症患者补充和综合医疗的跨专业循证咨询项目（“CCC-综合医疗”）的对照实施研究。
Front Med. 2024 Dec;18(6):1013-1025. doi: 10.1007/s11684-024-1097-z. Epub 2024 Nov 14.
6
Clinical and economic impact of pharmacist interventions to identify drug-related problems in multidisciplinary cancer care: a prospective trial.药剂师干预对多学科癌症护理中药物相关问题识别的临床和经济影响：一项前瞻性试验。
Oncologist. 2025 Aug 4;30(8). doi: 10.1093/oncolo/oyae213.
7
Oncology researchers' and clinicians' perceptions of complementary, alternative, and integrative medicine: an international, cross-sectional survey.肿瘤学研究人员和临床医生对补充医学、替代医学和整合医学的看法：一项国际、横断面调查。
Support Care Cancer. 2024 Aug 28;32(9):615. doi: 10.1007/s00520-024-08785-9.
8
Cancer Patients' Use of Apitherapy as Supportive Care: An Exploratory Study.癌症患者使用蜂疗作为支持性护理的探索性研究。
Eurasian J Med. 2024 Feb;56(1):15-20. doi: 10.5152/eurasianjmed.2024.22185.
9
Molecular Actions of Whole Plant Extract on HPV18-Infected Human Cervical Cancer (HeLa) Cells.植物全草提取物对 HPV18 感染的人宫颈癌（HeLa）细胞的分子作用。
Anticancer Agents Med Chem. 2024;24(17):1253-1263. doi: 10.2174/0118715206296375240703115848.
10
Association between dietary supplement use and mortality in cancer survivors with different body mass index and frailty status: a cohort study.不同体重指数和虚弱状态的癌症幸存者使用膳食补充剂与死亡率之间的关联：一项队列研究。
Front Nutr. 2024 May 1;11:1395362. doi: 10.3389/fnut.2024.1395362. eCollection 2024.
本文引用的文献
1
Complementary Medicine, Refusal of Conventional Cancer Therapy, and Survival Among Patients With Curable Cancers.补充医学、拒绝常规癌症治疗与可治愈癌症患者的生存。
JAMA Oncol. 2018 Oct 1;4(10):1375-1381. doi: 10.1001/jamaoncol.2018.2487.
2
Development of the adult and child complementary medicine questionnaires fielded on the National Health Interview Survey.成人和儿童补充医学问卷在国家健康访谈调查中的发展。
BMC Complement Altern Med. 2013 Nov 23;13:328. doi: 10.1186/1472-6882-13-328.
3
Reasons for and characteristics associated with complementary and alternative medicine use among adult cancer patients: a systematic review.成年癌症患者使用补充和替代医学的原因及相关特征：一项系统综述
Integr Cancer Ther. 2005 Dec;4(4):274-86. doi: 10.1177/1534735405282361.
4
Complementary and alternative medicine use by patients enrolled onto phase I clinical trials.参与I期临床试验的患者使用补充和替代医学的情况。
J Clin Oncol. 2004 Dec 1;22(23):4810-5. doi: 10.1200/JCO.2004.03.121.
Zotero 插件